A rare cause of congenital portosystemic shunt: type 2 Abernethy malformation [PDF]
The Abernethy malformation is characterised by congenital extrahepatic portosystemic shunts and is divided into two groups according to the type of anastomosis.
Danisan, G. +3 more
core +2 more sources
L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure [PDF]
Hyperammonemia is a feature of acute liver failure (ALF), which is associated with increased intracranial pressure (ICP) and brain herniation. We hypothesized that a combination of L-ornithine and phenylacetate (OP) would synergistically reduce toxic ...
Fuskevag, OM +8 more
core +2 more sources
Abernethy Malformation and Hepatocellular Carcinoma: a Serious Consequence of a Rare Disease [PDF]
Congenital portosystemic shunts (CPSS) are a rare vascular consequence of embryogenetic vascular alterations or the persistence of the fetal circulation elements, first described by John Abernethy in 1793 and classified by Morgan and Superina, into ...
Carvalho, AM +3 more
core +1 more source
Easy to say, hard to do. To the anniversary of two fundamental discoveries. Part 2 [PDF]
On the eve of the anniversaries of two historical events: the 145th anniversary of the experiments in which Eck's fistula was performed and the 55th anniversary of the successful clinical approbation of the selective distal splenorenal anastomosis, a ...
A. Yu. Anisimov
core +2 more sources
Reversal of Hypersplenism Following Orthotopic Liver Transplantation [PDF]
The purpose of this study was to clarify the effect of orthotopic liver transplantation on hypersplenism. In a 1-year period from July 1, 1986 to June 30, 1987, 196 adult patients underwent 233 orthotopic liver transplantations.
KATSUHIKO YANAGA +10 more
core +1 more source
Liver transplantation in the treatment of bleeding esophageal varices [PDF]
From March 1980 to July 1987, 1000 patients with various end-stage liver diseases received orthotopic liver transplants. Of the 1000 patients, three hundred two had definite histories of bleeding from esophageal varices before transplantation. There were
Gordon, RD +11 more
core
Could there be light at the end of the tunnel? Mesocaval shunting for refractory esophageal varices in patients with contraindications to transjugular intrahepatic portosystemic shunt. [PDF]
Cirrhotic patients with recurrent variceal bleeds who have failed prior medical and endoscopic therapies and are not transjugular intrahepatic portosystemic shunt candidates face a grim prognosis with limited options.
Borum, Marie L +2 more
core +2 more sources
Сравнительный анализ результатов дистального спленоренального анастомоза у пациентов с портальной гипертензией [PDF]
ГИПЕРТЕНЗИЯ ПОРТАЛЬНАЯЦИРРОЗЫ ПЕЧЕНИАНАСТОМОЗ ХИРУРГИЧЕСКИЙСПЛЕНОРЕНАЛЬНЫЙ ШУНТ ...
Бабаджанов, А. Х. +3 more
core
Current views on the treatment of portal hypertension [PDF]
There is no established treatment protocol for bleeding esophageal varices on which there is universal agreement between surgeons and physicians with special interest in the subject of portal hypertension.
Cuschieri, A.
core
Surgical Treatment of Portal Hypertension: Review of Henry Ford Hospital Experience [PDF]
Of 146 operations performed for the complications of portal hypertension in the Henry Ford Hospital between 1927 and August 31, 1969, 114 were portasystemic shunts. Operative mortality, sequelae and long term survival were closely related to the state of
Elliott, Joseph P., Jr. +2 more
core +1 more source

